CD244 and neoplasm: The introduction of CD244 as a critical co-stimulant molecule on the surfaces of NK cells, as a second and third generation CAR structure, can significantly enhance the anti-tumor effect of CAR-NK cells and reduce the inactivation of CAR-engineered cells caused by some tumor cells (109).